Skip to main content

Table 2 Detailed information of 8 differential metabolites identified in the case-cohort study

From: Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer

Metabolites

m/z

RT

P value

FDR

FC a

VIP

2-(2-butoxy ethoxy) ethanol

163.133

307.600

< 0.001

< 0.001

0.889

2.464

Caprylic acid

143.108

427.300

< 0.001

< 0.001

0.535

4.311

Diethyltoluamide

192.138

379.700

< 0.001

< 0.001

0.846

3.561

Dodecanoic acid

199.170

511.100

< 0.001

0.037

1.149

1.524

Hexamethylene glycol

283.175

221.900

< 0.001

0.030

0.663

1.823

Pelargonic acid

157.123

452.900

< 0.001

< 0.001

1.323

2.804

Pentaethylene glycol

239.149

213.300

< 0.001

0.028

0.665

1.726

Undecanoic acid

185.155

476.100

< 0.001

0.036

1.094

2.166

  1. m/z = Mass charge ratio, RT = Retention time, FDR = P value adjusted using false discovery rate, FC = Fold change, VIP = The variable importance in projection
  2. a Fold change was calculated as the ratio of the mean values of GEC cases to sub-cohort individuals